Literature DB >> 12759508

The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection.

D D Cochrane1, J R W Kestle.   

Abstract

The relationship of surgeon experience, measured by operative volume, to the outcomes of ventricular shunt treatment of hydrocephalus in children is not clear. This paper explores this relationship based on first ventriculoperitoneal shunts (VPS) implanted in English-speaking Canada during the period from April 1989 to March 2001. Three thousand seven hundred and ninety-four first VPS insertions, performed by 254 surgeons, were reviewed. Surgical experience was represented by the number of shunt operations performed during the study period by each surgeon prior to the date of the operation. The 6-month shunt failure risk for less experienced surgeons was 38%, compared to 31% for more experienced surgeons. This difference decreased to 4% at 60 months and 3% at 120 months (p = 0.001). The infection rate for initial shunt insertions was 7% for patients treated by more experienced surgeons and 9.4% for those treated by less experienced surgeons (p = 0.006). A relationship between surgeon experience and shunt outcome that appears to be based on the operative experience that a surgeon brings to a procedure is in keeping with clinical experience. This observation has implications for public policy, service planning and surgical mentorship during the earlier years of a surgeon's career. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12759508     DOI: 10.1159/000070413

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  30 in total

Review 1.  The role of different imaging modalities: is MRI a conditio sine qua non for ETV?

Authors:  Erik J van Lindert; Tjemme Beems; J André Grotenhuis
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

2.  Impact of surgical training on incidence of surgical site infection.

Authors:  Rachel Rosenthal; Walter P Weber; Marcel Zwahlen; Heidi Misteli; Stefan Reck; Daniel Oertli; Andreas F Widmer; Walter R Marti
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

3.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

Review 4.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

Review 5.  Shunt infections: a review and analysis of a personal series.

Authors:  Santosh Mohan Rao Kanangi; Chidambaram Balasubramaniam
Journal:  Childs Nerv Syst       Date:  2018-07-05       Impact factor: 1.475

6.  Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.

Authors:  Giovanni Raffa; Lucia Marseglia; Eloisa Gitto; Antonino Germanò
Journal:  Childs Nerv Syst       Date:  2015-03-28       Impact factor: 1.475

7.  Ventricular shunt complications in patients undergoing posterior vault distraction osteogenesis.

Authors:  Anthony Azzolini; Katie Magoon; Robin Yang; Scott Bartlett; Jordan Swanson; Jesse Taylor
Journal:  Childs Nerv Syst       Date:  2019-11-06       Impact factor: 1.475

8.  Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.

Authors:  Matthew R Test; Kathryn B Whitlock; Marcie Langley; Jay Riva-Cambrin; John R W Kestle; Tamara D Simon
Journal:  J Neurosurg Pediatr       Date:  2019-05-03       Impact factor: 2.375

9.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

10.  Cerebrospinal fluid shunt infection: risk factors and long-term follow-up.

Authors:  Matthieu Vinchon; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2006-03-14       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.